Levity Tirzepatide Cost: $1,299 Monthly for Branded Mounjaro

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Levity charges $1,299 every four weeks for branded Mounjaro (tirzepatide). New patients see a $50 first-month discount (bringing the first cycle to $1,249 with code WELCOME), but the standard recurring rate is $1,299 per cycle. Billing approximately every 28 days produces 13 cycles per year—$16,887 at the standard rate, or $16,837 when the first-month discount is applied—yielding an effective monthly cost of $1,407 (standard) or $1,403 (with discount). That price includes the medication, provider consultation, care coordination, and shipping; Levity does not charge a membership fee. The program offers only FDA-approved branded medications—Mounjaro, Ozempic, and Wegovy—no compounded formulations. Readers choosing branded tirzepatide for regulatory assurance will find Levity's structure straightforward; those prioritizing cost will find compounded alternatives at materially lower price points.

At-a-glance: Levity vs compounded tirzepatide

Levity pricing verified September 4, 2026. PlexusDx pricing current as of publication. 12-month totals and effective monthly figures are our calculations.

Levity's pricing structure in detail

Levity bills $1,299 every four weeks for Mounjaro—that is the standard recurring rate. New patients applying the code WELCOME at checkout receive a $50 first-month discount (verified September 4, 2026), bringing the initial cycle to $1,249. Subsequent cycles remain $1,299 each. Because Levity operates on an approximate 28-day billing cycle rather than calendar months, subscribers see 13 billing events over 12 months (365 days ÷ 28 ≈ 13.04 cycles). This cadence is less common than calendar-monthly billing and requires normalization to compare against programs that bill on the first of each month.

At the standard recurring rate across all 13 cycles, the 12-month cost is $16,887 per year—an effective $1,407 per month. With the $50 first-month discount applied, the sequence becomes $1,249 (cycle 1) + $1,299 × 12 (cycles 2–13) = $16,837 per year, or $1,403 per month effective.

Levity includes the medication, an initial consultation with a licensed provider, ongoing care coordination, and shipping in that single per-cycle charge. The program does not assess a separate membership fee, subscription charge, or consultation surcharge. Patients can cancel at any time; Levity does not require a contract or minimum commitment period.

Branded Mounjaro vs compounded tirzepatide: the regulatory trade-off

Levity dispenses only branded, FDA-approved medications—specifically Mounjaro for tirzepatide. Mounjaro has passed the FDA's pre-market review for safety, effectiveness, and manufacturing quality. Each vial carries lot-level traceability and the regulatory protections of a New Drug Application approval.

Compounded tirzepatide, by contrast, is prepared by a licensed 503A compounding pharmacy under a patient-specific prescription. Compounded medications are not FDA-approved; the FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Compounding pharmacies must follow state and federal quality standards, but compounded drugs do not undergo the pre-market approval process that branded medications complete.

That regulatory difference creates a price differential. PlexusDx compounded tirzepatide injection runs $289 per month with no commitment, $269 per month on a three-month prepaid plan, or $249 per month on a six-month prepaid plan. Over 12 months at the month-to-month rate, total cost is $3,468. Comparing Levity's standard recurring rate over 12 months ($16,887) to PlexusDx month-to-month ($3,468), the branded option costs $13,419 more per year, or $1,118 more per month. Even accounting for Levity's first-month discount (12-month total $16,837), the difference remains $13,369 per year or $1,114 per month.

Normalized 12-month comparison

Because Levity bills every four weeks and many competing programs bill monthly, direct comparison requires normalization to a common 12-month window. The table below shows total annual cost and the resulting effective monthly rate for each option.

All 12-month totals and effective monthly figures are our calculations. Levity standard recurring rate is $1,299 per ~4-week cycle; the first-month discounted figure of $1,249 (with code WELCOME) was verified September 4, 2026. PlexusDx pricing current as of publication. PlexusDx prepaid figures reflect the per-month rate when paying quarterly ($807 every three months) or biannually ($1,494 every six months).

The cost differential between Levity's standard recurring Mounjaro rate and PlexusDx compounded tirzepatide (month-to-month) is $13,419 per year, or $1,118 per month. Even after applying Levity's first-month discount, the gap remains $13,369 per year or $1,114 per month. Readers choosing branded medication accept that premium in exchange for FDA pre-market approval and the regulatory assurances that accompany a New Drug Application. Readers prioritizing cost and comfortable with compounded medication under a licensed clinician's supervision will find the compounded option materially less expensive.

What Levity includes

Levity's per-cycle charge covers:

• Medication: Branded Mounjaro in the dose prescribed by your provider.
• Provider consultation: Initial evaluation and prescription by a licensed clinician.
• Care coordination: Ongoing support and check-ins through the platform.
• Shipping: Delivery of medication to your address.

No separate membership fee, consultation charge, or subscription cost appears. The structure is all-inclusive at the per-cycle rate. Levity does not publish dose-specific pricing; the $1,299 figure applies regardless of whether you are on a starter dose or a maintenance dose, though dose assignment itself follows the FDA-approved titration schedule for Mounjaro.

Fees, commitments, and cancellation

Levity does not require a contract or minimum stay. Patients can cancel at any time. The program bills approximately every four weeks; canceling before the next billing date prevents the subsequent charge. Levity does not disclose a refund policy for medication already dispensed and shipped, so patients considering cancellation should confirm refund eligibility for the current cycle before proceeding.

No platform fee, no membership fee, no consultation surcharge. The standard recurring rate of $1,299 every four weeks (with a $50 first-month discount available via code WELCOME, verified September 4, 2026) is the total cost.

Dose policies and titration

Levity dispenses branded Mounjaro, which follows the FDA-approved titration protocol. Patients typically begin at 2.5 mg weekly and escalate every four weeks through 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg as tolerated and clinically appropriate. The prescribing provider determines the titration pace and target dose based on the patient's response, side-effect profile, and weight-loss progress.

Levity does not publish separate pricing for starter versus maintenance doses. Our dataset captures a single per-cycle rate of $1,299 regardless of dose. Readers requiring confirmation of dose-specific pricing should verify at intake or with Levity support before committing.

Decision factors

Levity's strengths

• Branded FDA-approved medication: Mounjaro has completed pre-market review for safety, efficacy, and quality. Each vial is traceable to a specific manufacturing lot with regulatory oversight.
• All-inclusive pricing: One charge covers medication, consultation, care, and shipping—no hidden fees or add-ons.
• No membership fee: Unlike some competitors that assess a recurring platform charge separate from medication cost, Levity rolls everything into the per-cycle price.
• Flexible cancellation: Cancel anytime without contract penalty.

Trade-offs and gaps

• Cost: At $16,887 per year (standard recurring rate) or $16,837 (with first-month discount), Levity is substantially more expensive than compounded tirzepatide alternatives. The branded-medication premium is approximately $13,400 annually compared to PlexusDx month-to-month compounded tirzepatide.
• Four-week billing cycle: Thirteen cycles per year complicates budgeting for readers accustomed to calendar-monthly billing. Two months each year will see two charges.
• No multi-month discounts: Levity offers only a single per-cycle rate. Programs offering three-month or six-month prepaid plans deliver lower effective monthly costs.
• Limited medication portfolio: Levity dispenses only branded medications. Readers seeking compounded semaglutide or tirzepatide, oral formulations, or microdose maintenance protocols must look elsewhere.
• No dose-specific pricing transparency: Our dataset does not confirm whether starter and maintenance doses carry the same per-cycle charge. Readers should verify if dose impacts cost.

Choose Levity if…

• You prioritize FDA-approved branded Mounjaro and are willing to pay a premium for pre-market regulatory review.
• You value the assurance of traceable, lot-controlled manufacturing and want to avoid compounded formulations.
• You prefer an all-inclusive pricing model with no separate membership or consultation fees.
• You can comfortably budget for an approximately $1,400 monthly medication cost and manage a four-week billing cycle.
• You want flexible cancellation without contract commitment.

Where PlexusDx fits

PlexusDx compounded tirzepatide injection runs $289 per month with no commitment, $269 per month on a three-month prepaid plan, or $249 per month on a six-month prepaid plan. Over 12 months, month-to-month cost totals $3,468—approximately $13,400 less than Levity's standard recurring Mounjaro rate ($16,887), or $13,369 less when comparing to Levity's first-month-discounted total ($16,837). PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician reviews your intake and determines whether compounded tirzepatide is appropriate for your situation.

The PlexusDx price includes the online provider visit, prescription, medication compounded to your prescribed dose, and shipping. No membership fee, no platform charge, no consultation surcharge. You can cancel anytime; three-month and six-month plans are prepaid but deliver progressively lower per-month costs for readers who prefer longer commitment in exchange for budget predictability.

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx also offers oral tirzepatide capsules and a low-dose maintenance protocol for readers stepping down from injectable therapy or seeking an oral route.

Methodology and freshness

We verified Levity's Mounjaro pricing through a checkout-process capture on September 4, 2026. The standard recurring rate of $1,299 per ~4-week cycle was observed directly, along with the promotional code WELCOME delivering a $50 first-month discount (first cycle $1,249). Levity's approximately four-week billing cadence is documented in the program's recurring-charge disclosures. We calculated the 13-cycle annual total by multiplying the per-cycle rate by 13 (365 ÷ 28 ≈ 13.04 cycles, rounded to 13 full cycles), then divided by 12 to derive the effective monthly cost. PlexusDx pricing is current as of publication date (September 15, 2026). All 12-month totals, effective monthly figures, and cost differentials are our calculations based on the verified per-cycle or per-month rates.

We reviewed Levity's Trustpilot profile and conducted Reddit searches for complaint themes; no rating volume or specific negative themes were captured in this pass. This article reflects pricing and structure only; we do not report on service quality, support responsiveness, or patient satisfaction in the absence of coded review evidence.

Frequently Asked Questions

Does Levity charge the same price for every Mounjaro dose?

Levity's advertised rate is $1,299 every four weeks regardless of dose, though we have not confirmed explicit dose-tier pricing. Branded Mounjaro follows an FDA-approved titration starting at 2.5 mg and escalating through 15 mg. Readers should verify at intake whether the per-cycle charge remains flat across all dose levels or if higher maintenance doses carry a surcharge.

How does Levity's four-week billing cycle affect my annual cost?

Billing every 28 days produces approximately 13 cycles per year instead of 12 calendar months. At the standard recurring rate of $1,299 per cycle, you will pay $16,887 over 12 months—an effective $1,407 per month. With the first-month discount ($1,249 for cycle one, then $1,299 for subsequent cycles), the 12-month total is $16,837 or $1,403 effective monthly. Two months each year will see two billing events instead of one, so budget planning should account for that timing.

Can I use insurance or a manufacturer coupon with Levity?

Our dataset does not document insurance billing or compatibility with Lilly's manufacturer savings card for Mounjaro. Levity operates as a direct-pay telehealth program, and the $1,299 rate suggests full retail pricing. Readers hoping to apply insurance or manufacturer assistance should confirm eligibility and claims-submission process with Levity before enrolling.

What happens if I want to switch from Levity to a compounded provider?

Levity allows cancellation at any time. If you cancel before your next billing date, you will not be charged for the subsequent cycle. To transfer to a compounded-tirzepatide program, complete the new provider's intake; a licensed clinician will review your history, current dose, and medical appropriateness. Most programs can continue your current dose if clinically appropriate, though a brief re-titration or overlap period may occur. Confirm the transfer protocol with both providers to avoid a gap in medication.

Does Levity offer other GLP-1 medications besides Mounjaro?

Yes. Levity dispenses branded Ozempic (semaglutide) at a standard recurring rate of $1,199 per cycle and Wegovy (semaglutide) at $1,599 per cycle (both offer a $50 first-month discount with code WELCOME; verified September 4, 2026). Levity does not offer compounded semaglutide or tirzepatide; all medications are FDA-approved branded formulations. Readers seeking compounded options or oral routes will need to consider alternative providers.

Sources

• Levity website and intake process, accessed September 4, 2026
• Levity checkout verification and promotional-code capture, September 4, 2026
• Levity Trustpilot profile review, September 4, 2026
• PlexusDx tirzepatide injection product page, accessed September 15, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.